BRIEF published on 12/02/2024 at 06:05, 1 year 6 months ago Bucher Industries propose d'élargir son conseil d'administration avec Manja Greimeier Technologie Automobile Extension Du Conseil D'administration Bucher Industries Manja Greimeier Expérience En Gestion
PRESS RELEASE published on 12/02/2024 at 06:00, 1 year 6 months ago Enlargement of the board of directors Bucher Industries AG to propose Manja Greimeier as new board member with extensive international management experience at AGM in April 2025 Board Of Directors AGM Bucher Industries Manja Greimeier International Management
BRIEF published on 10/24/2024 at 06:05, 1 year 8 months ago Le ralentissement du marché correspond aux attentes de Bucher Industries Marge Opérationnelle Baisse Des Ventes Optimisation Des Coûts Ralentissement Du Marché Bucher Industries
BRIEF published on 10/24/2024 at 06:05, 1 year 8 months ago Market Slowdown Aligns with Bucher Industries' Expectations Cost Optimization Sales Decline Operating Margin Market Slowdown Bucher Industries
PRESS RELEASE published on 10/24/2024 at 06:00, 1 year 8 months ago Market slowdown in line with expectations Market slowdown affects Bucher Industries AG's 9-month figures as demand declines, with some segments harder hit. Group anticipates lower sales and profit margin for 2024 Sales Decline Market Slowdown Operating Profit Margin Bucher Industries AG 9-month Figures
PRESS RELEASE published on 07/25/2024 at 06:00, 1 year 11 months ago Solid result in a volatile environment
PRESS RELEASE published on 04/25/2024 at 06:00, 2 years 2 months ago Sales below the prior-year period with weaker market momentum, as expected
BRIEF published on 04/18/2024 at 17:57, 2 years 2 months ago Bucher Industries AG annonce l'approbation de toutes les propositions du conseil d'administration lors de l'AGA 2024 Dividende Gouvernance D'Entreprise Assemblée Générale Annuelle Initiatives Environnementales Bucher Industries AG
BRIEF published on 04/18/2024 at 17:57, 2 years 2 months ago Bucher Industries AG Announces Approval of All Board Proposals at 2024 AGM Annual General Meeting Corporate Governance Dividend Environmental Initiatives Bucher Industries AG
PRESS RELEASE published on 04/18/2024 at 17:52, 2 years 2 months ago Annual general meeting 2024: all proposals of the board of directors approved Bucher Industries AG's AGM 2024 approves all board proposals incl. CHF 13.50 dividend/share. Successful 2023 financial year highlighted with various sustainability measures implemented Annual General Meeting Financial Year Dividend Bucher Industries AG Sustainability Measures
Published on 06/26/2026 at 14:05, 3 hours 14 minutes ago SouthGobi Announces Voting Results of Annual General Meeting of Shareholders
Published on 06/26/2026 at 14:00, 3 hours 19 minutes ago Dateline Chairman Invests $1.95 million through Options Exercise
Published on 06/26/2026 at 13:00, 4 hours 19 minutes ago Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
Published on 06/26/2026 at 12:45, 4 hours 34 minutes ago Northern Dynasty Reports Oral Arguments Held
Published on 06/26/2026 at 17:05, 14 minutes ago NAKIKI SE Receives an Adverse Opinion on Its 2024 Financial Statements and Management Report
Published on 06/26/2026 at 17:00, 19 minutes ago Darwin AG Announces Results of the 2026 Annual General Meeting
Published on 06/26/2026 at 15:30, 1 hour 49 minutes ago JMGO Extends Special Savings Beyond Prime Day with N3 Ultimate at Its Best Price Since Launch
Published on 06/26/2026 at 15:23, 1 hour 56 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 06/26/2026 at 07:00, 10 hours 19 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 10 hours 19 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel